Wen-fang M. Tang

Guangdong Provincial Key Laboratory Of Translational Medicine In Lung Cancer
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

ASO Visual Abstract: Pathologic Response, Tumor Microenvironment Dynamics, and Survival Dissociation After Neoadjuvant Chemoimmunotherapy for Lung Cancer With Rare Histologic Subtypes.

ASO Visual Abstract: Pathologic Response, Tumor Microenvironment Dynamics, and Survival Dissociation After Neoadjuvant Chemoimmunotherapy for Lung Cancer With Rare Histologic Subtypes.

Journal: Annals of surgical oncology

Published: July 31, 2026

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Pathological Response, Tumor Microenvironment Dynamics, and Survival Dissociation after Neoadjuvant Chemoimmunotherapy for Lung Cancer with Rare Histological Subtypes.

Journal: Annals of surgical oncology

Published: March 12, 2026

Age-Associated Targetable Genomic Alterations and PD-L1 Expression in 2509 Patients With Pulmonary Ground-Glass Opacities.

Age-Associated Targetable Genomic Alterations and PD-L1 Expression in 2509 Patients With Pulmonary Ground-Glass Opacities.

Journal: Cancer medicine

Published: December 18, 2025

ASO Author Reflections: The Heterogenicity of EGFR Mutations in Patients with Pulmonary Ground-Glass Opacities.

ASO Author Reflections: The Heterogenicity of EGFR Mutations in Patients with Pulmonary Ground-Glass Opacities.

Journal: Annals of surgical oncology

Published: December 27, 2024

Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases.

Deciphering genomic evolution of metastatic organotropism with 535 paired primary lung cancers and metastases.

Journal: Cell reports

Published: December 11, 2024

EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities.

EGFR Mutation Rates Correlate with Age at Diagnosis and Tumor Characteristics in Patients with Pulmonary Ground-Glass Opacities.

Journal: Annals of surgical oncology

Published: June 03, 2024

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201).

Journal: Clinical lung cancer

Published: June 26, 2023

Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer.

Acquired DNA damage repairs deficiency-driven immune evolution and involved immune factors of local versus distant metastases in non-small cell lung cancer.

Journal: Oncoimmunology

Published: June 01, 2023

Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.

Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer.

Journal: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

Published: February 24, 2023

A novel image deep learning-based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.

A novel image deep learning-based sub-centimeter pulmonary nodule management algorithm to expedite resection of the malignant and avoid over-diagnosis of the benign.

Journal: European radiology

Published: February 20, 2023

Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone.

Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone.

Journal: Frontiers in oncology

Published: October 06, 2022

Dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer.

Dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer.

Journal: Thoracic cancer

Published: March 27, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026